Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 26/2/2020
SIETES contiene 92916 citas

 1 a 20 de 396 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Becker WC, Fiellin DA. Abuse-deterrent opioid formulations - Putting the potential benefits into perspective. N Engl J Med 2017;376:2103-5. [Ref.ID 101625]
2. Cita con resumen
Ostrow L, Jessell L, Hurd M, Darrow SM, Cohen D. Discontinuing psychiatric medications: a survey of long-term users . Psychiatric Services 2017;68:1232-8. [Ref.ID 101485]
3.Enlace a cita original
Barrenberg E, Garbe E. Use of over-the counter (OTC) drugs and perceptions of OTC drug safety among German adults. Eur J Clin Pharmacol 2015;71:1389-96. [Ref.ID 99626]
4.Enlace a cita original Cita con resumen
Feliz J. National study: teens report higher use of performance enhancing substances. Partnership for drug-free kids 2014:22 de julio. [Ref.ID 97750]
5. Cita con resumen
Spielmans GI, Kirsch I. Drug approval and drug effectiveness. Annual Review of Clinical Psychology 2014;214:741-66. [Ref.ID 97582]
6. Cita con resumen
Adler JN, Colbert JA. Medicinal use of marijuana - Polling results. N Engl J Med 2013;368:e30. [Ref.ID 95553]
7. Cita con resumen
Dell'osso B, Lader M. Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal. European Psychiatry 2013;28:7-20. [Ref.ID 94663]
8.Tiene citas relacionadas
Drazen JM. Believe the data. N Engl J Med 2012;367:1152-3. [Ref.ID 93773]
9.Tiene citas relacionadas Cita con resumen
Kesselheim AS, Robertson CT, Myers JA, Rose SL, Gillet V, Ross KM, Glynn RJ, Joffe S, Avorn J. A randomized study of how physicians interpret research funding disclosures. N Engl J Med 2012;367:1119-27. [Ref.ID 93771]
10.Enlace a cita original Cita con resumen
Hudson B, Zarifeh A, Young L, Wells JE. Patients' expectations of screening and preventive treatments. Ann Fam Med 2012;10:495-502. [Ref.ID 93236]
11.Tiene citas relacionadas Cita con resumen
Herzig S, Rothberg M. Drug prophylaxis in general medical patients: does usage reflect the benefits and risks?. BMJ 2012;344:21-3. [Ref.ID 93191]
12. Cita con resumen
Fenton JJ, Jerant AF, Bertakis KD, Franks P. The cost of satisfaction. A national study of patient satisfaction, health care utilization, expenditures, and mortality. Arch Intern Med 2012;172:405-11. [Ref.ID 92513]
13. Cita con resumen
Rahmner PB, Eiermann B, Korkmaz S, Gustafsson LL, Gurvén M, Maxwell S, Eichle H-G, Vég A. Physicians' reported needs of drug information at point of care in Sweden. Br J Clin Pharmacol 2012;73:115-25. [Ref.ID 92249]
14. Cita con resumen
Anónimo. Side effects have women stopping aromatase inhibitors early. DIA Daily 2011:12 de diciembre. [Ref.ID 91681]
15. Cita con resumen
Woloshin S, Schwartz LM. Communicating data about the benefits and harms of treatment. A randomized trial. Ann Intern Med 2011;155:87-96. [Ref.ID 91391]
17. Cita con resumen
Buiting HM, Rurup ML, Wijsbek H, van Zuylen L, den Hartogh G. Understanding provision of chemotherapy to patients with end stage cancer: qualitative interview study. BMJ 2011;342:857. [Ref.ID 90411]
18. Cita con resumen
Anónimo. Resultados clínicos de medicamentos de marca frente a genéricos: una revisión actualizada a 28/02/11. Boletín Terapéutico Extremeño 2011;2:1-8. [Ref.ID 90001]
19. Cita con resumen
Emery J, McKenzie A, Bulsara C, Holman D'Arcy. Next goal: consistency of packaging and labelling. BMJ 2010;341:64. [Ref.ID 88869]
20.Enlace a cita original
Lea D, Spigset O, Slordal L. Norwegian medical students' attitudes towards the pharmaceutical industry. Eur J Clin Pharmacol 2010;66:727-33. [Ref.ID 88816]
Seleccionar todas
 1 a 20 de 396 siguiente >>